Your browser doesn't support javascript.
loading
Myeloid-derived suppressor cells are associated with impaired Th1 and Th17 responses and severe pulmonary paracoccidioidomycosis which is reversed by anti-Gr1 therapy.
Preite, Nycolas Willian; Kaminski, Valéria de Lima; Borges, Bruno Montanari; Calich, Vera Lúcia Garcia; Loures, Flávio Vieira.
Affiliation
  • Preite NW; Institute of Science and Technology, Federal University of São Paulo, São José dos Campos, São Paulo, Brazil.
  • Kaminski VL; Institute of Science and Technology, Federal University of São Paulo, São José dos Campos, São Paulo, Brazil.
  • Borges BM; Institute of Science and Technology, Federal University of São Paulo, São José dos Campos, São Paulo, Brazil.
  • Calich VLG; Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
  • Loures FV; Institute of Science and Technology, Federal University of São Paulo, São José dos Campos, São Paulo, Brazil.
Front Immunol ; 14: 1039244, 2023.
Article in En | MEDLINE | ID: mdl-36776848

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paracoccidioidomycosis / Myeloid-Derived Suppressor Cells Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Brazil

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paracoccidioidomycosis / Myeloid-Derived Suppressor Cells Type of study: Risk_factors_studies Limits: Animals Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Brazil